OTOSPECTRINE ušné kvapky, suspenzia
OTOSPECTRINE ušné kvapky, suspenzia
Authorised
- NEOMYCIN SULFATE
- POLYMYXIN B SULFATE
- Lidocaine hydrochloride
- Sulfiram
- Dexamethasone
Product identification
Medicine name:
OTOSPECTRINE ušné kvapky, suspenzia
Active substance:
- NEOMYCIN SULFATE
- POLYMYXIN B SULFATE
- Lidocaine hydrochloride
- Sulfiram
- Dexamethasone
Target species:
-
Dog
-
Cat
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
NEOMYCIN SULFATE5000.00/international unit(s)1.00millilitre(s)
-
POLYMYXIN B SULFATE10000.00/international unit(s)1.00millilitre(s)
-
Lidocaine hydrochloride40.00/milligram(s)1.00millilitre(s)
-
Sulfiram50.00/milligram(s)1.00millilitre(s)
-
Dexamethasone1.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Ear drops, suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Package description:
- Available only in Slovak
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Base Pharmaceuticals B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- USKVBL
Authorisation number:
- 96/096/00 - S
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Slovak (PDF)
Published on: 19/01/2022